GB8512163D0 - Oxothiazolidine compound - Google Patents

Oxothiazolidine compound

Info

Publication number
GB8512163D0
GB8512163D0 GB858512163A GB8512163A GB8512163D0 GB 8512163 D0 GB8512163 D0 GB 8512163D0 GB 858512163 A GB858512163 A GB 858512163A GB 8512163 A GB8512163 A GB 8512163A GB 8512163 D0 GB8512163 D0 GB 8512163D0
Authority
GB
United Kingdom
Prior art keywords
alkyl
sup
compound
alkylcarbamoyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB858512163A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB858512163A priority Critical patent/GB8512163D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of GB8512163D0 publication Critical patent/GB8512163D0/en
Priority to US06/855,904 priority patent/US4764514A/en
Priority to CA000507952A priority patent/CA1274515A/en
Priority to ZA863285A priority patent/ZA863285B/xx
Priority to DE8686303458T priority patent/DE3677413D1/de
Priority to EP86303458A priority patent/EP0203743B1/en
Priority to AT86303458T priority patent/ATE60762T1/de
Priority to AU57276/86A priority patent/AU593247B2/en
Priority to FI861935A priority patent/FI861935A7/fi
Priority to IL78750A priority patent/IL78750A/xx
Priority to KR1019860003700A priority patent/KR860009009A/ko
Priority to GR861243A priority patent/GR861243B/el
Priority to NO86861907A priority patent/NO861907L/no
Priority to JP61110095A priority patent/JPS61267562A/ja
Priority to ES554901A priority patent/ES8800185A1/es
Priority to HU861972A priority patent/HU195200B/hu
Priority to DK222386A priority patent/DK222386A/da
Priority to SU864027524A priority patent/SU1545941A3/ru
Priority to SU874202533A priority patent/SU1493107A3/ru
Priority to ES557660A priority patent/ES8802503A1/es
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Lubricants (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
GB858512163A 1985-05-14 1985-05-14 Oxothiazolidine compound Pending GB8512163D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB858512163A GB8512163D0 (en) 1985-05-14 1985-05-14 Oxothiazolidine compound
US06/855,904 US4764514A (en) 1985-05-14 1986-04-24 Oxothiazolidine compound and composition containing same
CA000507952A CA1274515A (en) 1985-05-14 1986-04-30 Oxothiazolidine compound
ZA863285A ZA863285B (en) 1985-05-14 1986-05-01 Oxothiazolidine compound
DE8686303458T DE3677413D1 (de) 1985-05-14 1986-05-07 Oxothiazolidinderivate.
EP86303458A EP0203743B1 (en) 1985-05-14 1986-05-07 Oxothiazolidine compound
AT86303458T ATE60762T1 (de) 1985-05-14 1986-05-07 Oxothiazolidinderivate.
AU57276/86A AU593247B2 (en) 1985-05-14 1986-05-08 Oxothiazolidine compounds
FI861935A FI861935A7 (fi) 1985-05-14 1986-05-09 Oxotiazolidinfoerening.
IL78750A IL78750A (en) 1985-05-14 1986-05-11 Oxothiazolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SU864027524A SU1545941A3 (ru) 1985-05-14 1986-05-13 Способ получени оксотиазолидиновых соединений
KR1019860003700A KR860009009A (ko) 1985-05-14 1986-05-13 옥소티아졸리딘 화합물의 제조방법
GR861243A GR861243B (en) 1985-05-14 1986-05-13 Process for the preparation of oxothiazolidine compound
NO86861907A NO861907L (no) 1985-05-14 1986-05-13 Fremgangsmaate for fremstilling av terapeutisk aktive oksotiazolidin-forbindelser.
JP61110095A JPS61267562A (ja) 1985-05-14 1986-05-13 オキソチアゾリジン化合物
ES554901A ES8800185A1 (es) 1985-05-14 1986-05-13 Un procedimiento para preparar derivados de oxotiazolidina
HU861972A HU195200B (en) 1985-05-14 1986-05-13 Process for producing oxo-thiazolidine compounds and pharmaceutical preparations comprising the same
DK222386A DK222386A (da) 1985-05-14 1986-05-13 Oxathiazolidinderivater
SU874202533A SU1493107A3 (ru) 1985-05-14 1987-05-13 Способ получени производных оксотиазолидина или их солей
ES557660A ES8802503A1 (es) 1985-05-14 1987-08-13 Un procedimiento para preparar derivados de oxotiazolidina.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858512163A GB8512163D0 (en) 1985-05-14 1985-05-14 Oxothiazolidine compound

Publications (1)

Publication Number Publication Date
GB8512163D0 true GB8512163D0 (en) 1985-06-19

Family

ID=10579098

Family Applications (1)

Application Number Title Priority Date Filing Date
GB858512163A Pending GB8512163D0 (en) 1985-05-14 1985-05-14 Oxothiazolidine compound

Country Status (18)

Country Link
US (1) US4764514A (cg-RX-API-DMAC7.html)
EP (1) EP0203743B1 (cg-RX-API-DMAC7.html)
JP (1) JPS61267562A (cg-RX-API-DMAC7.html)
KR (1) KR860009009A (cg-RX-API-DMAC7.html)
AT (1) ATE60762T1 (cg-RX-API-DMAC7.html)
AU (1) AU593247B2 (cg-RX-API-DMAC7.html)
CA (1) CA1274515A (cg-RX-API-DMAC7.html)
DE (1) DE3677413D1 (cg-RX-API-DMAC7.html)
DK (1) DK222386A (cg-RX-API-DMAC7.html)
ES (2) ES8800185A1 (cg-RX-API-DMAC7.html)
FI (1) FI861935A7 (cg-RX-API-DMAC7.html)
GB (1) GB8512163D0 (cg-RX-API-DMAC7.html)
GR (1) GR861243B (cg-RX-API-DMAC7.html)
HU (1) HU195200B (cg-RX-API-DMAC7.html)
IL (1) IL78750A (cg-RX-API-DMAC7.html)
NO (1) NO861907L (cg-RX-API-DMAC7.html)
SU (2) SU1545941A3 (cg-RX-API-DMAC7.html)
ZA (1) ZA863285B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0755937B2 (ja) * 1986-07-29 1995-06-14 日本曹達株式会社 オキサ（チア）ゾリジン誘導体その製造方法及び殺ダニ剤
CA1322199C (en) * 1987-07-15 1993-09-14 Masami Eigyo N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia
DE3875073T2 (de) * 1987-11-20 1993-03-11 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl)-4-thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
US5066665A (en) * 1990-05-21 1991-11-19 Warner-Lambert Co. Substituted isoxazolidin-3-ones and derivatives thereof acting at muscarinic receptors
DE4404848A1 (de) * 1994-02-16 1995-08-17 Hoechst Ag Substituierte Cyclohexanolester, ihre Verwendung zur Behandlung von Krankheiten und pharmazeutische Präparate
CA2191874C (en) 1994-06-03 2008-05-20 Christopher Ian Brightwell Novel processes and intermediates for the preparation of piperazine derivatives
EP0783504B1 (en) * 1994-09-16 2000-03-15 Novo Nordisk A/S [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE AS ANTAGONISTS OF AMPA-RECEPTORS
US5596011A (en) * 1995-04-06 1997-01-21 Repine; Karen M. Method for the treatment of macular degeneration
US6359134B1 (en) 1997-05-30 2002-03-19 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
CN1290254A (zh) 1998-02-05 2001-04-04 武田药品工业株式会社 氨磺酰衍生物及其制备和用途
US6710061B2 (en) 2001-03-09 2004-03-23 Ortho-Mcneil Pharamceutical, Inc. Aminopyrrolidine sulfonamides as serine protease inhibitors
US6538017B2 (en) 2001-03-09 2003-03-25 Ortho-Mcneil Pharmaceutical, Inc. Aminopyrrolidine sulfonamides as serine protease inhibitors
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3309377A (en) * 1964-10-19 1967-03-14 Sterling Drug Inc 3-[(2-oxazolidinone-3-yl)-alkyl]-4-thiazolidinones and their preparation
IT1194793B (it) * 1981-05-12 1988-09-28 Corvi Camillo Spa Derivati tiazolidinici ad attivita' farmacologica,procedimento per la loro preparazione e composizioni farmaceutiche contenenti detti derivati
DE3315424A1 (de) * 1983-04-28 1984-12-20 Cassella Ag, 6000 Frankfurt Substituierte piperazin-1-yl-essigsaeure-amide, verfahren zu ihrer herstellung und ihre verwendung
FR2552762B1 (fr) * 1983-09-30 1986-07-25 Delalande Sa Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique
PT83152B (pt) * 1985-08-09 1989-03-30 Lilly Co Eli Processo para a preparacao de compostos di-t-butilfenoicos

Also Published As

Publication number Publication date
ES8802503A1 (es) 1988-07-16
SU1493107A3 (ru) 1989-07-07
DE3677413D1 (de) 1991-03-14
HUT41014A (en) 1987-03-30
KR860009009A (ko) 1986-12-19
HU195200B (en) 1988-04-28
FI861935A0 (fi) 1986-05-09
US4764514A (en) 1988-08-16
CA1274515A (en) 1990-09-25
ZA863285B (en) 1986-12-30
AU5727686A (en) 1986-11-20
ES8800185A1 (es) 1987-11-01
ATE60762T1 (de) 1991-02-15
ES557660A0 (es) 1988-07-16
EP0203743A1 (en) 1986-12-03
GR861243B (en) 1986-08-28
ES554901A0 (es) 1987-11-01
IL78750A0 (en) 1986-08-31
EP0203743B1 (en) 1991-02-06
JPS61267562A (ja) 1986-11-27
IL78750A (en) 1990-12-23
FI861935A7 (fi) 1986-11-15
NO861907L (no) 1986-11-17
AU593247B2 (en) 1990-02-08
JPH0455431B2 (cg-RX-API-DMAC7.html) 1992-09-03
DK222386D0 (da) 1986-05-13
DK222386A (da) 1986-11-15
SU1545941A3 (ru) 1990-02-23

Similar Documents

Publication Publication Date Title
IL93050A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL107426A0 (en) Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same
IL98872A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA863285B (en) Oxothiazolidine compound
IL109615A (en) Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
AU4536389A (en) Anti-antherosclerotic diaryl compounds
IL112098A0 (en) Sulfamate derivatives and pharmaceutical compositions containing them
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
GB8504072D0 (en) Cephem compounds
IL90424A0 (en) Cephem derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ222741A (en) Pharmaceutical compositions containing an interferon and a purine derivative
IL82629A0 (en) Substituted 6-hydroxymethyl-carbapenem antibiotics,the preparation thereof and pharmaceutical compositions containing them
CA2102812A1 (en) Cholesterol-lowering tocopherol analogs
IL93594A0 (en) Pharmaceutical compositions containing an imidazopyrimidone derivative
WO1987004435A3 (en) Xanthine compounds
ES8404343A1 (es) Un procedimiento para la prepracion de nuevos derivados de 1,4-diaminociclitol.
EP0306863A3 (en) New cephem compounds and processes for preparation thereof
BG95629A (en) Derivatives of 10, 11, 12, 13 - tetrahytdrodesmicozine, method for preparing them, and their use as pharmaceutical preparations
ES8306152A1 (es) Un procedimiento para la preparacion de nuevos derivados de 7-oxo-1-azabiciclo (3.2.0) hepteno.